Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project

Abstract

Background Guideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project aimed to standardize medical practice using quality indicators (QIs) as indices to evaluate the quality of medical practice. In this study, we have reported the quality indicator values of prescription before the beginning of the guideline lectures in the EGUIDE project to ascertain the baseline status of treating patients with schizophrenia. Methods A cross‐sectional, retrospective case record survey was conducted, involving 1164 patients with schizophrenia at the time of discharge. We checked all types and dosage of psychotropic drugs. Results Forty‐three percent of patients had antipsychotic polypharmacy, and substantial concomitant medication was observed (antidepressants; 8%, mood stabilizers: 37%, anxiolytics or hypnotics: 68%). Conclusions In the results obtained in this study, we plant to report changes in the effectiveness of education in the EGUIDE project near the future.

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study

“…The EGUIDE project has two sets of implementation content, the development of the CPGs and lectures associated with the CPGs, and three quality indicators, clinical knowledge, clinical behavior, and prescribing behavior. 10 , 11 This study aimed to examine the effect of revision of the lecture materials on improvements in clinical knowledge in 2017 based on the feedback loop from evaluation of clinical knowledge following lectures on the CPGs (Figure 1 ).…”

“…[7][8][9] To disseminate and implement these two CPGs, the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project was started in 2016. 10,11 The EGUIDE project started with the cooperation of 22 hospitals, and as of 2020, more than 180 hospitals (44 universities) participated. In brief, education programs for psychiatrists regarding these two CPGs are provided throughout Japan.…”

Improvements in the Degree of Understanding the Treatment Guidelines for Schizophrenia and Major Depressive Disorder in a Nationwide Dissemination and Implementation Study

“…The EGUIDE projecthas two sets of implementation content, the development of the CPGs and lectures associated with the CPGs, and three quality indicators, clinical knowledge, clinical behavior, and prescribing behavior [7,8]. This study aimed to examine the effect of revision of the lecture materials on improvements in clinical knowledge in 2017 based on the feedback loop from evaluation of clinical knowledge following lectures on the CPGs (Figure 1).…”

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study

“…The EGUIDE project has two sets of implementation content, namely, the development of the CPGs and lectures associated with the CPGs, and three quality indicators, namely, clinical knowledge, clinical behavior, and prescribing behavior [7,8]. This study aimed to examine the effect of revising the lecture materials on improvements in clinical knowledge in 2017 based on the feedback loop from evaluating clinical knowledge following lectures on the CPGs (Fig 1).…”

“…On the other hand, CPG dissemination and implementation strategies for psychiatric disorders have not been established to date [6]. To disseminate and implement these two CPGs, the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project was started in 2016 [7,8]. The EGUIDE project started with the cooperation of 22 hospitals, and as of 2020, more than 180 hospitals (44 universities) participated.…”